CY1114983T1 - Συνθεση για τη θεραπεια της κυστικης ινωσης - Google Patents
Συνθεση για τη θεραπεια της κυστικης ινωσηςInfo
- Publication number
- CY1114983T1 CY1114983T1 CY20141100210T CY141100210T CY1114983T1 CY 1114983 T1 CY1114983 T1 CY 1114983T1 CY 20141100210 T CY20141100210 T CY 20141100210T CY 141100210 T CY141100210 T CY 141100210T CY 1114983 T1 CY1114983 T1 CY 1114983T1
- Authority
- CY
- Cyprus
- Prior art keywords
- treatment
- cystic fibrosis
- composition
- prostacyclin
- prevention
- Prior art date
Links
- 201000003883 Cystic fibrosis Diseases 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 abstract 2
- 229960001123 epoprostenol Drugs 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 150000003815 prostacyclins Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5578—Eicosanoids, e.g. leukotrienes or prostaglandins having a pentalene ring system, e.g. carbacyclin, iloprost
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
- A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Physiology (AREA)
- Otolaryngology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Η παρούσα εφεύρεση παρέχει συνθέσεις οι οποίες περιέχουν προστακυκλίνη ή ανάλογο προστακυκλίνης, ή φαρμακευτικώς αποδεκτό άλας της για χρήση στην πρόληψη ή θεραπεία της κυστικής ίνωσης. Η εφεύρεση παρέχει επίσης τη χρήση τυποποιημένης συσκευασίας που περιέχει προστακυκλίνη ή ανάλογο προστακυκλίνης για τη θεραπεία ή πρόληψη πάθησης που σχετίζεται με την κυστική ίνωση σε άτομο.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09167491 | 2009-08-07 | ||
| EP10739941.2A EP2461812B1 (en) | 2009-08-07 | 2010-08-05 | Composition for the treatment of cystic fibrosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1114983T1 true CY1114983T1 (el) | 2016-12-14 |
Family
ID=41382119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20141100210T CY1114983T1 (el) | 2009-08-07 | 2014-03-18 | Συνθεση για τη θεραπεια της κυστικης ινωσης |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US20120184622A1 (el) |
| EP (1) | EP2461812B1 (el) |
| JP (1) | JP5877787B2 (el) |
| KR (1) | KR101729800B1 (el) |
| CN (1) | CN102548559B (el) |
| AU (1) | AU2010280684B2 (el) |
| BR (1) | BR112012002578B8 (el) |
| CA (1) | CA2770066C (el) |
| CL (1) | CL2012000319A1 (el) |
| CY (1) | CY1114983T1 (el) |
| DK (1) | DK2461812T3 (el) |
| EA (1) | EA023720B1 (el) |
| ES (1) | ES2451790T3 (el) |
| GT (1) | GT201200038A (el) |
| HN (1) | HN2012000297A (el) |
| HR (1) | HRP20140277T1 (el) |
| IL (1) | IL217899B (el) |
| PL (1) | PL2461812T3 (el) |
| PT (1) | PT2461812E (el) |
| RS (1) | RS53234B (el) |
| SG (1) | SG178315A1 (el) |
| SI (1) | SI2461812T1 (el) |
| SM (1) | SMT201400057B (el) |
| WO (1) | WO2011015630A1 (el) |
| ZA (1) | ZA201200790B (el) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20180036807A (ko) | 2009-06-12 | 2018-04-09 | 맨카인드 코포레이션 | 한정된 비표면적을 갖는 디케토피페라진 마이크로입자 |
| US10213464B2 (en) * | 2011-01-13 | 2019-02-26 | Scipharm Sarl | Method for enhancing engraftment of haematopoetic stem cells |
| AU2012215606B2 (en) | 2011-02-07 | 2016-12-22 | Scipharm Sarl | Novel composition for the treatment of cystic fibrosis |
| US9505737B2 (en) | 2013-01-11 | 2016-11-29 | Corsair Pharma, Inc. | Treprostinil derivative compounds and methods of using same |
| JP6542128B2 (ja) | 2013-01-11 | 2019-07-10 | コルセア ファーマ インコーポレイテッド | トレプロスチニルのプロドラッグ |
| AU2014228415B2 (en) | 2013-03-15 | 2018-08-09 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
| CA2918369C (en) | 2013-07-18 | 2021-06-29 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
| SI3060041T1 (sl) | 2013-10-25 | 2021-04-30 | Insmed Incorporated | Spojine prostaciklina |
| AU2015349969B2 (en) | 2014-11-18 | 2020-02-06 | Insmed Incorporated | Methods of manufacturing treprostinil and treprostinil derivative prodrugs |
| US9643911B2 (en) | 2015-06-17 | 2017-05-09 | Corsair Pharma, Inc. | Treprostinil derivatives and compositions and uses thereof |
| US9394227B1 (en) | 2015-06-17 | 2016-07-19 | Corsair Pharma, Inc. | Treprostinil derivatives and compositions and uses thereof |
| JP2019519489A (ja) | 2016-05-05 | 2019-07-11 | リクイディア・テクノロジーズ・インコーポレーテッド | 肺高血圧症を治療するための乾燥粉末トレプロスチニル |
| CA3038276A1 (en) | 2016-09-26 | 2018-03-29 | United Therapeutics Corporation | Treprostinil prodrugs |
| CN114072136B (zh) | 2019-04-29 | 2024-11-29 | 英斯梅德股份有限公司 | 曲前列素前药的干粉组合物及其使用方法 |
| CN114616225A (zh) | 2019-08-23 | 2022-06-10 | 联合治疗公司 | 曲前列环素前药 |
| WO2021211916A1 (en) | 2020-04-17 | 2021-10-21 | United Therapeutics Corporation | Treprostinil for use in the treatment of intersitial lung disease |
| US11793780B2 (en) | 2020-06-09 | 2023-10-24 | United Therapeutics Corporation | Prodrugs of treprosiinil |
| WO2022132655A1 (en) | 2020-12-14 | 2022-06-23 | United Therapeutics Corporation | Methods of treating disease with treprostinil prodrugs |
| EP4301372A1 (en) | 2021-03-03 | 2024-01-10 | United Therapeutics Corporation | A dry powder composition of trestinil and its prodrug thereof and further comprising comprising (e)-3,6-bis[4-(n-carbonyl-2-propenyl)amidobutyl]-2,5-diketopiperazine (fdkp) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3744941B2 (ja) * | 1997-03-14 | 2006-02-15 | 東レ株式会社 | プロスタグランジンｉ誘導体徐放性製剤 |
| US20010006979A1 (en) * | 1998-07-08 | 2001-07-05 | Richard Stratton | Method for treatment of fibrosis related diseases by the administration of prostacyclin derivatives |
| WO2003030912A1 (en) * | 2001-08-31 | 2003-04-17 | Sucampo Ag | Prostaglandin analogs as chloride channel opener |
| US7550133B2 (en) * | 2002-11-26 | 2009-06-23 | Alexza Pharmaceuticals, Inc. | Respiratory drug condensation aerosols and methods of making and using them |
| ES2622471T5 (es) * | 2003-05-22 | 2020-07-23 | United Therapeutics Corp | Compuestos y procedimientos para la administración de análogos de prostaciclina |
| US20040265238A1 (en) * | 2003-06-27 | 2004-12-30 | Imtiaz Chaudry | Inhalable formulations for treating pulmonary hypertension and methods of using same |
| US20080096915A1 (en) * | 2005-01-13 | 2008-04-24 | Greenberg Traurig LLP | Compositions for the treatment of metabolic disorders |
| ATE551059T1 (de) * | 2005-10-26 | 2012-04-15 | Asahi Kasei Pharma Corp | Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie |
| SI1993557T1 (sl) * | 2006-02-03 | 2016-01-29 | Actelion Pharmaceuticals Ltd. | Nova formulacija epoprostenola in postopek izdelave le-te |
| US20080280986A1 (en) * | 2007-02-09 | 2008-11-13 | United Therapeutics Corporation | Treprostinil treatment for interstitial lung disease and asthma |
-
2010
- 2010-08-05 SG SG2012008702A patent/SG178315A1/en unknown
- 2010-08-05 JP JP2012523343A patent/JP5877787B2/ja active Active
- 2010-08-05 CA CA2770066A patent/CA2770066C/en not_active Expired - Fee Related
- 2010-08-05 EP EP10739941.2A patent/EP2461812B1/en active Active
- 2010-08-05 BR BR112012002578A patent/BR112012002578B8/pt not_active IP Right Cessation
- 2010-08-05 EA EA201200253A patent/EA023720B1/ru not_active IP Right Cessation
- 2010-08-05 PT PT107399412T patent/PT2461812E/pt unknown
- 2010-08-05 RS RS20140134A patent/RS53234B/sr unknown
- 2010-08-05 PL PL10739941T patent/PL2461812T3/pl unknown
- 2010-08-05 SI SI201030560T patent/SI2461812T1/sl unknown
- 2010-08-05 KR KR1020127003535A patent/KR101729800B1/ko active Active
- 2010-08-05 CN CN2010800454199A patent/CN102548559B/zh not_active Expired - Fee Related
- 2010-08-05 WO PCT/EP2010/061428 patent/WO2011015630A1/en not_active Ceased
- 2010-08-05 US US13/389,281 patent/US20120184622A1/en not_active Abandoned
- 2010-08-05 HR HRP20140277AT patent/HRP20140277T1/hr unknown
- 2010-08-05 DK DK10739941.2T patent/DK2461812T3/da active
- 2010-08-05 ES ES10739941.2T patent/ES2451790T3/es active Active
- 2010-08-05 AU AU2010280684A patent/AU2010280684B2/en not_active Ceased
-
2012
- 2012-02-01 ZA ZA2012/00790A patent/ZA201200790B/en unknown
- 2012-02-02 IL IL217899A patent/IL217899B/en active IP Right Grant
- 2012-02-07 GT GT201200038A patent/GT201200038A/es unknown
- 2012-02-07 CL CL2012000319A patent/CL2012000319A1/es unknown
- 2012-02-07 HN HN2012000297A patent/HN2012000297A/es unknown
-
2014
- 2014-03-18 CY CY20141100210T patent/CY1114983T1/el unknown
- 2014-04-29 SM SM201400057T patent/SMT201400057B/xx unknown
-
2015
- 2015-12-22 US US14/978,914 patent/US10086001B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1114983T1 (el) | Συνθεση για τη θεραπεια της κυστικης ινωσης | |
| CY1119826T1 (el) | Θεραπευτικες συνθεσεις που περιεχουν μακιτεντανη | |
| ECSP10010724A (es) | Compuestos de isoindol 5-sustituidos | |
| CY1119167T1 (el) | Αναστολεις toy nkcc για τη θεραπεια του αυτισμου | |
| EA201070786A1 (ru) | Бензофуропиримидиноны | |
| CY1118231T1 (el) | Συνθεση λιποσωματος | |
| EA201170441A1 (ru) | Терапевтические противовирусные пептиды | |
| CY1114981T1 (el) | Προφαρμακα ντολουτεγκραβιρης | |
| CY1112558T1 (el) | Ενωσεις ν-μεθυλαμινομεθυλο ισοϊνδολης και συνθεσεις που τις περιλαμβανουν και μεθοδοι χρησης τους | |
| CY1118478T1 (el) | Παραγωγα τυπου αζαϊνδαζολιου ή διαζαϊνδαζολιου για τη θεραπεια του πονου | |
| EA201390908A1 (ru) | Производные бицикло[3.2.1]октиламида и их применение | |
| CO6480927A2 (es) | Derivados de imidazolin-2-ona 1,3-disustituida como inhibidores de cyp17. | |
| CY1115043T1 (el) | Φαρμακευτικο σκευασμα | |
| NO20081554L (no) | Isoindollmidforbindelser og sammensetninger omfattende samme, og anvendelse derav | |
| EA201170872A1 (ru) | Ингибиторы протеинкиназы | |
| EA201390428A1 (ru) | Композиции и способы лечения легочной гипертензии | |
| CY1118093T1 (el) | Φαρμακοτεχνικες μορφες που περιλαμβανουν παραγωγα 1-(bhta-d-γλυκοπυρανοζυλ)-2-θειενυλμεθυλβενζολιου ως αναστολεις sglt | |
| MX2012007375A (es) | 3-ceto-n-propargil 1-aminoindano. | |
| CY1121898T1 (el) | Ενωσεις αμιδιου ως αγωνιστες tου υποδοχεα 5-ht4 | |
| PT2310356E (pt) | Derivados de adamantildiamida e a sua utilização | |
| EA201201263A1 (ru) | Фармацевтическая композиция, содержащая этексилат дабигатрана | |
| EA201290772A1 (ru) | Новые формы ивабрадина гидрохлорида | |
| CY1119999T1 (el) | Καινοτομος συνθεση για τη θεραπευτικη αντιμετωπιση της κυστικης ινωσης | |
| CY1123056T1 (el) | Νεα μορφη χορηγησης της ρασεκαδοτριλης | |
| CY1115556T1 (el) | Φαρμακευτικη συνθεση για χορηγηση απο το στομα η οποια περιλαμβανει ετεξιλικη δαβιγατρανη |